Cargando…
Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy
BACKGROUND: The main role of the cell cycle is to enable error-free DNA replication, chromosome segregation and cytokinesis. One of the best characterised checkpoint pathways is the spindle assembly checkpoint, which prevents anaphase onset until the appropriate attachment and tension across kinetoc...
Autores principales: | Faisal, Amir, Mak, Grace W Y, Gurden, Mark D, Xavier, Cristina P R, Anderhub, Simon J, Innocenti, Paolo, Westwood, Isaac M, Naud, Sébastien, Hayes, Angela, Box, Gary, Valenti, Melanie R, De Haven Brandon, Alexis K, O'Fee, Lisa, Schmitt, Jessica, Woodward, Hannah L, Burke, Rosemary, vanMontfort, Rob L M, Blagg, Julian, Raynaud, Florence I, Eccles, Suzanne A, Hoelder, Swen, Linardopoulos, Spiros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418449/ https://www.ncbi.nlm.nih.gov/pubmed/28334731 http://dx.doi.org/10.1038/bjc.2017.75 |
Ejemplares similares
-
Structure-Based Design of
Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine
Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)
por: Naud, Sébastien, et al.
Publicado: (2013) -
Introduction of
a Methyl Group Curbs Metabolism of
Pyrido[3,4-d]pyrimidine Monopolar Spindle
1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical
Candidate N(2)-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N(8)-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)
por: Woodward, Hannah L., et al.
Publicado: (2018) -
Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosis
por: Gurden, Mark D., et al.
Publicado: (2016) -
Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species
por: Wood, Francesca L., et al.
Publicado: (2019) -
Differences in MPS I and MPS II Disease Manifestations
por: Hampe, Christiane S., et al.
Publicado: (2021)